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PPhosphorylcholine-Targeting
Immunization Reduces Atherosclerosis
Giuseppina Caligiuri, MD, PHD,* Jamila Khallou-Laschet, PHD,* Marta Vandaele, MSC,*
Anh-Thu Gaston, BSC,* Sandrine Delignat, BSC,* Chantal Mandet, BSC,†
Heinz V. Kohler, MD, PHD,‡ Srini V. Kaveri, DVM, PHD,* Antonino Nicoletti, PHD*
Paris, France; and Lexington, Kentucky
Objectives The present study evaluated the effect of phosphorylcholine (PC) immunization on the extent of experimental
atherosclerosis.
Background Immunization against oxidized lipoprotein (oxLDL) or Streptococcus pneumoconiae reduces atherosclerosis.
Phosphorylcholine is the main epitope recognized by both antipneumococcus and anti-oxLDL antibodies. There-
fore we reasoned that PC-specific antibodies might play an important role in atherogenesis.
Methods Apolipoprotein E knockout mice were immunized with PC every second week over 4 months. At the end of the
study, serum antibodies directed to either PC or oxLDL were measured. Splenic and peritoneal B cells were ana-
lyzed by flow cytometry. Aortic root atherosclerotic lesions were quantified by morphometry and phenotyped by
immunohistochemistry. Immune and control sera were also tested for their effect on foam cell formation in
macrophage culture in the presence of oxLDL.
Results The PC-immunized mice showed 3-fold increase in titers of anti-PC and -oxLDL antibodies compared with control
mice (p  0.01). The PC-immunized mice also showed a significant increase in the number of splenic mature
B cells. The extent of atherosclerotic aorta root lesions was reduced by 40% in the PC-immunized mice (p 
0.01). Immunohistochemistry showed reduced expression of major histocompatibility complex class II antigens
(p  0.05) and the presence of B-cell clusters in plaques of PC-immunized mice. Finally, PC-immune serum was
able to reduce macrophage-derived foam cell formation in the presence of oxLDL in vitro.
Conclusions Phosphorylcholine immunization drives a specific humoral immune response that reduces foam cell formation
in vitro and is atheroprotective in vivo. (J Am Coll Cardiol 2007;50:540–6) © 2007 by the American College of
Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2006.11.054r
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entibodies directed to oxidized low-density lipoproteins
oxLDL) are a hallmark of atherosclerosis (1), and immu-
ization to oxLDL reduces experimental atherosclerosis
2,3) independently of CD4 T-cell help (4). Selected
eptide sequences from the protein of LDL (apoB-100)
nduce atheroprotective antibodies and have been proposed
s immunization tools for coronary heart disease (5). How-
ver, major histocompatibility complex (MHC) polymor-
hism will impede the use of generic vaccinating peptides.
urthermore, the main epitope of anti-oxLDL antibodies is
ot contained in the protein portion of the molecule but
rom the *Centre de Recherche des Cordeliers, Université Pierre et Marie Curie-
aris 6, Paris, France; †Centre de Recherche des Cordeliers, Université René
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y Université Pierre et Marie Curie-Paris 6, INSERM, and the Fondation de France.
he first two authors contributed equally to this work.t
Manuscript received October 11, 2005; revised manuscript received October 6,
006, accepted November 16, 2006.ather in the phospholipids and has been identified as
hosphorylcholine (PC) (6).
See page 547
In recent years, a large amount of research has focused on
he immune-inflammatory response associated with athero-
clerosis and its clinical manifestations. Whereas the T-cell–
ediated arm of the specific immunity seems to play a
roatherogenic role (4,7–13), the B-cell compartment is
ikely to be atheroprotective. Indeed, B-lymphocyte defi-
iency increases atherosclerosis in the atherosclerosis-prone
DL receptor knockout (KO) mouse model (14), and we
ave shown that removal of the spleen, one of the main
-cell organs, leads to a dramatic aggravation of the disease
n the apolipoprotein E (apoE) KO mouse model (15).
nterestingly, it was shown at the same time that genetically
ngineered asplenic or splenectomized mice have, respec-
ively, a total absence or a dramatic reduction of the B-1a
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August 7, 2007:540–6 Anti-PC Antibodies and Atherosclerosisell population, which is associated with the inability to
ount an immune response to streptococcal infections (16).
recent work by Binder et al. has demonstrated that
neumococcal vaccination decreases atherosclerotic lesion
ormation via a molecular mimicry between S. pneumoniae
nd oxLDL (17). The same group had previously shown
hat C-reactive protein binds to oxLDL and apoptotic cells
hrough recognition of phosphorylcholine (18). The genes
ncoding the antigen binding site of anti-oxLDL antibodies
n apoE KO mice are structurally indistinguishable from
ntibodies produced by the T15 B-1 cell clones, which are
pecific for PC (19) and confer optimal protection against
ethal infection with S. pneumoniae (20).
Thus, PC is the common target of the atheroprotective
ntibodies directed to oxLDL or S. pneumoniae. We there-
ore hypothesized that anti-PC humoral immunity might
irectly impact atherogenesis.
ethods
nimals. The apoE KO mice from our breeding facility
ere maintained on a regular chow diet and kept in standard
onditions. All experiments conformed to “Position of the
merican Heart Association on Research Animal Use,”
dopted on November 11, 1984.
nti-PC immunization. The immunization protocol
tarted in 8-week-old female apoE KO mice (n  8/group)
nd was scheduled every second week. As an adjuvant, we
hose the oligonucleotide CpG, because we have recently
hown that among several adjuvants tested (Alum, CpG,
omplete and incomplete Freund’s adjuvants), CpG is the
nly one that does not possess intrinsic atheromodulating
roperties (21). Mice received IP injections (100 l/
njection) of either phosphate-buffered saline (PBS) or the
826 CpG oligonucleotide (synthesized with a nuclease-
esistant phosphorothioate backbone; 500 g/mouse/
njection; Operon Quiagen, Alameda, California) coupled
o keyhole limpet hemocyanin (KLH; Biosearch Technol-
gies, Novato, California) or the 1826 CpG oligonucleotide
oupled to PC-KLH (22). Mice were euthanized after 4
onths of treatment.
issue processing. Blood was collected either by a retro-
rbital puncture to follow the antibody titers during the
xperiment or by cardiac puncture at death. At death,
eritoneal cells were harvested by a lavage with 2 ml RPMI
640. Peritoneal cells were centrifuged at 300 g for 5 min at
°C. Erythrocytes were lysed with ammonium chloride/
otassium carbonate (ACK) buffer, and the remaining
eukocytes were washed before staining for flow cytometry.
he aorta and the spleen were dissected. Blood was centri-
uged at 4°C for 5 min at 12,000 g, and serum was stored at
20°C until analysis. Total serum cholesterol (TC) level
as measured using a commercial kit (méthode “CHOD-
AP;” Boehringer, Mannheim, Germany). The aortic root
as dissected under a microscope and embedded in opti-
um cut temperature medium, snap frozen, and sectioned. muantification of atheroscle-
otic lesions. The aortic root le-
ions were quantified as previ-
usly described (23). Briefly, 10-
m-thick serial cryostat sections
ere cut from the proximal 1
m of the aortic root. The mean
esion size in each animal was
etermined by computer-assisted
orphometry (Leica Qwin cus-
omized program) on 4 hematox-
lin/oil red-O–stained sections
ut at 200, 400, 600, and 800 m
rom the cusp origin.
mmunohistologic analyses. Immunohistochemistry and
esion morphology analysis were performed on serial aortic
ryosections at 50-m intervals between 500 m and 700
m from the cusp origin. Slides were air dried, fixed in cold
cetone, and washed in water and PBS. Biotinylated pri-
ary antibodies were revealed with avidin alkalin-
hosphatase (Vectastain ABC kit; Vector Laboratories,
urlingame, California) and Fast Red substrate (Dako,
lostrup, Denmark). Anti-T15 antibodies were kindly
rovided by John Kearney, University of Alabama, Birming-
am. The other primary antibodies were purchased from
D Biosciences (San Jose, California) and directed against
Ab (MHC II), CD3 (T cells), and CD19 (B cells). Primary
ntibodies were revealed by alkaline phosphatase-
onjugated secondary antibodies and Fast Red substrate.
lides were counterstained by hematoxylin. Positive (red)
taining was quantified by computer-assisted image analysis.
he cellular/extracellular components of plaques was ana-
yzed on Masson’s trichrome-stained cryosections.
low cytometry analysis. Spleen cell suspensions were
repared by meshing the tissue on 100-m nylon filters and
y lysing erythrocytes with the ACK buffer. Nonsplenic
control) leukocytes were obtained by peritoneal lavage.
plenocytes and peritoneal leukocytes were stained for 30
in at 4°C with 2 combinations of monoclonal antibodies
o identify B-cell populations: IgD-FITC/CD5-CyChrome/
gM-biotinylatedAvidin-PE and IgM-FITC/CD5-PE/
D45RB220-CyChrome. All antibodies were from BD Bio-
ciences. Cells were analyzed with a FACSCalibur (BD
iosciences) flow cytometer.
DL preparation. The LDL (1.019  d  1.063) was
solated by ultracentrifugation from pooled untouched apoE
O mouse plasma collected on EDTA. Protein content was
etermined by the Bradford method with bovine serum
lbumin (BSA) as standard. Copper-oxidized LDL was
repared by incubation of LDL (1 mg/ml) with 5 mol/l
u2 for 24 h at 37°C. Before incubation with cells, oxLDL
as dialyzed against PBS 3 times.
LISA. Total IgG and IgM and specific antibodies to
xLDL, PC, and KLH were quantified using customized
nzyme-linked immunosorbent assay (ELISA). For deter-
Abbreviations
and Acronyms
ApoE  apolipoprotein E
KLH  keyhole limpet
hemocyanin
KO  knockout
oxLDL  oxidized low-
density lipoprotein
PBS  phosphate-buffered
saline
PC  phosphorylcholine
TC  total cholesterolination of total Ig, F(ab=)2 fragments of antimouse IgG
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ciences) were used as capture antibodies. For determination
f specific antibodies, oxLDL (10 g/ml), PC-BSA (2
g/ml), and KLH (10 g/ml) were coated onto the ELISA
late wells. For competitive ELISA, PC-BSA (Biosearch
echnologies) was plated onto the 96-well enzyme immu-
oassay plate and oxLDL was used as competitive antigen.
ncreasing concentrations of oxLDL were coincubated with
he sera for 1 h at room temperature. Preliminary experi-
ents indicated that 2 g/ml was the optimal concentration
f coated PC-BSA. Increasing dilutions of individual sera
ere tested for anti-PC IgG, and the dilution correspond-
ng to 50% of the maximal IgG binding was used for the
ompetitive ELISA (1:20). Total and antigen-specific IgG
ere revealed using antimouse IgG (Calbiochem, Darm-
Figure 1 Active Anti-PC Immunization Is Atheroprotective
Extent of lesion development was analyzed by computer-assisted morphometry on
immunization protocol started in 8-week-old female apolipoprotein E knockout mic
injections of either phosphate-buffered saline (PBS) or the adjuvant coupled to eith
after 4 months of treatment. (Top) Quantification of lesion size in cross-sections o
(Bottom) Representative micrographs of oil red O-stained images from the 3 grou
PBS or KLH (2-way analysis of variance).tadt, Germany) and antimouse IgM (BD Biosciences)
lkaline phosphatase-conjugated secondary antibodies and
-nitrophenylphosphate disodic salt substrate. Plates were
ead at 405 nm. Data were read in duplicates; intra- and
nterassay variability were 5% and 20%, respectively.
solation of peritoneal macrophages. Six- to 8-week-old
57Bl/6 female mice (Charles River) received an IP injec-
ion of 2 ml thioglycollate medium (3%) 4 days before
eritoneal macrophage harvesting by lavage. Cells were
esuspended in complete DMEM supplemented with 10%
etal calf serum (FCS) and 20% of L-929 conditioned
edium (source of CSF-1) and seeded at 0.8  106/well in
-well Lab-Tek chamber slides. After 2 h of incubation at
7°C in a 5% CO2 incubator, nonadherent cells were
emoved by gentle washing and adherent cells were incu-
O-stained and hematoxylin-counterstained serial sections of the aortic root. The
was scheduled every second week. Mice (n  8/group) received intraperitoneal
hole limpet hemocyanin (KLH) or phosphorylcholine (PC)-KLH. Mice were killed
aortic root at the specified distance from the appearance of the first cusp.
he specified distance from the appearance of the first cusp. *p  0.01 versusoil red
e and
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August 7, 2007:540–6 Anti-PC Antibodies and Atherosclerosisated in complete DMEM 10% FCS  20% L929-
onditioned medium for 24 h. Cells were further cultured
or 12 h before experiments in the same conditions but
ithout FCS. With these conditions, 80% cells were
dentified as MAC-3 macrophages by flow cytometry and
mmunofluorescent microscopy (data not shown). Macro-
hages were then washed and incubated with or without
reshly prepared oxLDL (50 g/ml) and with or without 50
g/ml of serum from PBS or CpG-PC–treated mice. After
5 h of incubation, macrophages were washed, fixed with
% paraformaldehyde, stained with oil red O, and counter-
tained with hematoxylin. Lab-Tek slides were mounted
nder coverslip, and internalized LDL was analyzed on 3
andom fields per condition captured with a CCD camera
onnected to a phase-contrast light microscope and a
ustomized program written with Qwin (Leica, Wetzlar,
ermany).
tatistical analysis. Results are expressed as mean SEM.
ne-way (group effect) or 2-way (group and distance
ffects) analysis of variance was performed using Statview
.0 software (SAS Institute, Cary, North Carolina). Bon-
erroni post hoc test was used to evaluate the differences
etween each group. Differences between groups were
onsidered to be significant if p  0.05.
esults
C immunization reduces atherogenesis in apoE KO
ice. Seven-week-old apoE KO mice were immunized or
ot with PC coupled to the KLH hapten carrier (22). The
C levels and body weights were equivalent in all groups.
s shown in Figure 1, the control groups of mice that
eceived the KLH alone or PBS developed lesions of similar
ize. Mice immunized with PC-KLH displayed lesions
40% smaller in size than control mice. Proportionally to
he decrease in lesion size, lesions in PC-KLH immunized
ice contained less extracellular matrix and fewer cells than
ontrol mice (Table 1).
C immunization raises both anti-PC and anti-oxLDL
ntibody titers. Anti-PC immunization induces both IgM
nd IgG production (20,24,25). Total circulating IgG or
gM were not significantly affected by the immunization
rotocol (Fig. 2). As expected, anti-KLH antibodies were
ncreased in both PC-KLH– and KLH-treated mice (data
ot shown). However, only PC-KLH–immunized mice
erum Cholesterol, Body Weight,nd Ather sclerotic Morphologic Analysis
Table 1 Serum Cholesterol, Body Weight,and Atherosclerotic Morphologic Analysis
PBS (n  8) KLH (n  8) PC-KLH (n  8)
TC (g/l) 3.3 0.3 3.6 0.3 3.3 0.3
Weight (g) 28 1 29 2 29 2
ECM (m2  103) 25 9 26 10 19 6
Cells (m2  103) 22 7 24 8 15 5
he surface areas of the extracellular matrix (ECM) and of cells were analyzed by Masson’s
richrome staining and computer-assisted morphometry on digital images.m
KLH keyhole limpet hemocyanin; PBS  phosphate-buffered saline; PC  phosphorylcholine;
C  total cholesterol.howed a significant increase in the serum titers of anti-PC
gG and IgM (Fig. 2), substantiating the efficiency of the
mmunization protocol. Importantly, serum IgG and IgM
rom PC-KLH–immunized mice displayed also a much
tronger reactivity against oxLDL compared with sera
rom control apoE KO mice (Fig. 3), and competitive
LISA showed that increasing doses of oxLDL compete
ith anti-PC IgG in apoE KO mouse sera (Fig. 3), in
greement with earlier findings that anti-oxLDL anti-
odies in apoE KO mice are indeed targeted to phos-
horylcholine (26).
C-immune apoE KO mouse serum reduces oxLDL
ptake by cultured macrophages. The incubation of
erum-deprived macrophages with oxLDL increased by 4.7
imes the intracellular oil red O staining (Fig. 4). Addition
f serum from nonimmunized apoE KO mice significantly
ncreased the oxLDL uptake (Fig. 4), possibly because of
he excess of lipoproteins contained in the hypercholester-
lemic mouse serum, which is spontaneously oxidized in the
ulture conditions (27). In contrast, oxLDL uptake was
imilar to the one observed in the absence of mouse serum
n PC-immunized mice in the presence of similar hyper-
holesterolemia but with 3-fold higher titers of anti-oxLDL
nd anti-PC antibodies compared with nonimmunized
Figure 2 PC Immunization Raises Anti-PC IgG and IgM
Enzyme-linked immunosorbent assays were performed on sera collected at
death (similar results were obtained on sera collected by retro-orbital puncture
9 weeks after the first immunization) to measure total immunoglobulin (Ig)G
and IgM as well as anti-phosphorylcholine (PC) IgG and IgM titers. Individual
sera from each mouse were tested at 1:10 dilution for specific antibodies and
at 1:50 dilution for total antibodies. Data are represented as mean  SEM for
each group of treatment. *p  0.05 versus PBS or KLH (1-way analysis of vari-
ance). OD  optical density; other abbreviations as in Figure 1.ice (Fig. 3).
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Anti-PC Antibodies and Atherosclerosis August 7, 2007:540–6Figure 3 PC Immunization Also Raises Anti-oxLDL IgG and IgM
(Left and center) Enzyme-linked immunosorbent assays (ELISA) were performed on sera collected at death to measure IgG and IgM anti-oxidized low-density lipoprotein
(oxLDL) titers. Individual sera from each mouse were tested at increasing dilutions (from 1:6.25 to 1:100). Data are represented as mean  SEM for each group of
treatment. Reactivity against native LDL was not different from background signal (data not shown). *p  0.05 versus phosphate-buffered saline or keyhole lympet
hemocyanin (1-way analysis of variance). (Right) Competitive ELISA was performed by coating 2 g/ml PC-bovine serum albumin (BSA) onto enzyme immunoassay
plates and using serum dilutions corresponding to 50% of maximal binding on 2 g/ml PC-BSA as determined by preliminary experiments. Increasing concentrations of
oxLDL were coincubated with the individual sera for 1 h at room temperature. As shown, the level of binding of anti-PC IgG decreased with increasing concentrations of
oxLDL, suggesting competition of the 2 antigens for the same antibodies. Abbreviations as in Figures 1 and 2.Figure 4 Immune Sera Prevent oxLDL Uptake by Macrophages
Thioglycollate-elicited peritoneal macrophages were cultured on LabTek slide chambers during 24 h with complete DMEM medium supplemented with 10% fetal calf
serum (FCS) and 20% L-929 conditioned medium. Macrophages were then deprived of FCS for 12 h before a 15-h incubation with or without oxidized low-density lipopro-
tein (50 g/ml) and with or without serum (50 g/ml) from phosphate-buffered saline (Ctrl) or PC-immunized mice (PC-KLH). Internalized LDL were stained with oil red O,
and 3 random fields per condition were observed with phase-contrast microscopy (magnification 200). A customized program written with Qwin (Leica) was used to
quantify the intracellular oil red O staining. The mean (SEM) of intracellular staining per field is expressed in arbitrary units (au). A representative field and cell (frame)
is shown for each condition. *p  0.05 versus oxLDL without serum (1-way analysis of variance). Abbreviations as in Figures 1 and 3.
B
m
e
m
r
p
c
c
i
I

P
t
l
t
(
l
m
C
s
o
D
A
h
e
t
e
p
(
a
p
a
e
r
m
m
c
O
i
o
i
e
d
a
r
o
B
a
545JACC Vol. 50, No. 6, 2007 Caligiuri et al.
August 7, 2007:540–6 Anti-PC Antibodies and Atherosclerosis-cell activity and homing to plaques in PC-immunized
ice. The evaluation of B-cell populations by flow cytom-
try (IgMhigh IgD Transitional T1 B cells, IgMhigh IgDdull
arginal zone T1 B cells, IgMhigh IgDhigh T2 B cells)
evealed that they were not affected in the spleen or the
eritoneum (data not shown). On the contrary, mature B
ells analyzed either as IgMdull IgDhigh or as IgMhigh B220
ells were significantly increased in the spleen of PC-KLH
mmunized mice but not in the peritoneum (mean of
gMhigh B220 mature B cells in spleen  SEM: KLH 9.3
2.9%; PC-KLH 16.1  2.6% [p  0.05 vs. KLH and
BS]; PBS 10.6  0.7%).
Immunohistochemistry of atherosclerotic lesions showed
he presence of T15 antibodies, which were enriched in the
esions of PC-immunized mice. Furthermore, B-cell clus-
ers were observed in 7 of 9 mice immunized with PC-KLH
Figs. 5 and 6). In contrast, fewer I-Ab cells (activated
eukocytes) were detected in the lesions of PC-immunized
ice (Figs. 5 and 6). Although enriched in the adventitia,
D3 cells (T lymphocytes) were only occasionally ob-
erved within the atherosclerotic plaques (Fig. 5) regardless
f the treatment.
Figure 5 T15 Antibodies and Cell
Infiltrates in Lesions of PC-Immunized Mice
Representative micrograph showing immunohistochemistry from atherosclerotic
lesions of phosphorylcholine (PC)-immunized apolipoprotein E knockout mice. T
lymphocytes were detected using an anti-CD3 antibody, B cells with an anti-
CD19 antibody, MHC II cells with an anti–I-Ab antibody, and T15 antibodies
deposited in the lesions with the F6 anti-T15 antiidiotypic antibody (a kind gift
from Dr. John Kearney, University of Alabama, Birmingham). Positive cells are
stained red (hematoxyilin counterstaining). Original magnification 200. A 
adventitia; L  lumen.wiscussion
growing body of evidence suggests that the spontaneous
umoral immune response developed in parallel with ath-
rosclerosis is tentatively protective. In particular, it appears
hat antibodies recognizing PC, such as the germline-
ncoded B-1 cell natural antibodies, T15 (19), the anti-
neumococcus antibodies (17), and anti-oxLDL antibodies
2,3), reduce atherosclerosis. Thus, natural or induced
ntibodies reacting with PC might dynamically orchestrate
rotective host responses in infection, autoimmunity, and
therosclerosis (28).
The present study provides direct support to this hypoth-
sis by showing that active PC immunization succeeds in
educing lesion size in the atherosclerosis-prone apoE KO
ice. The intensity of protection conferred by active im-
unization to PC is in the range of the atheroprotection
onferred by oxLDL (3) or pneumococcal vaccination (17).
f note, in parallel with anti-PC specific antibodies, PC
mmunization was able to raise the titers of serum anti-
xLDL antibodies to 3-fold higher than those of control-
mmunized apoE KO mice, further supporting the hypoth-
sis that anti-oxLDL antibodies are indeed elicited by and
irected to the PC on oxLDL (6). The rise in anti-oxLDL
ntibodies did not alter the TC levels, in agreement with the
ecent finding that such antibodies fail to alter the clearance
f oxLDL in apoE KO mice (29).
Active PC immunization resulted in activation of the
-cell compartment in parallel with enrichment of B cells
nd T15-like antibodies within the atherosclerotic plaques
Figure 6 Quantification of Infiltrated Cells
in Plaques of PC-Immunized Mice
Immunohistochemistry was performed using anti–I-Ab (inflammatory cells) and
anti-CD19 (B lymphocytes) primary antibodies. Positive cells were revealed by
alkaline phosphatase-conjugated secondary antibodies and fast red substrate.
Slides were counterstained by hematoxylin. Positive (red) staining was quanti-
fied by computer-assisted image analysis, and data are expressed as percent-
age of total cells. Inflammatory cells were significantly reduced in plaques of
PC-immunized apolipoprotein E (apoE) knockout (KO) mice. In contrast, the
number of infiltrating B lymphocytes was increased in PC-immunized apoE KO
mice. *p  0.05 versus PBS; **p  0.01 versus KLH or PBS (1-way analysis
of variance). Abbreviations as in Figure 1.here their protective function is likely optimized while
b
n
t
f
a
a
f
m
s
t
t
c
i
g
o
T
a
n
o
v
t
e
s
a
R
I
C
F
R
1
1
1
1
1
1
1
1
1
1
2
2
2
2
2
2
2
2
2
2
546 Caligiuri et al. JACC Vol. 50, No. 6, 2007
Anti-PC Antibodies and Atherosclerosis August 7, 2007:540–6eing restricted topologically. Among the various mecha-
isms by which T15 antibodies can exert atheroprotection,
he blockade of oxLDL uptake by macrophages, and thus of
oam cell formation, has been proposed (19). Indeed,
nti-PC IgM could mask the very epitopes on oxLDL that
re recognized by macrophage scavenger receptors (19). We
ound that oxLDL uptake by serum-deprived cultured
acrophages significantly increased in the presence of
erum from nonimmunized apoE KO mice possibly owing
o its abundance in lipoproteins spontaneously oxidized in
he culture conditions (27). In spite of similar cholesterol
ontent, we did not observe any increase of oxLDL uptake
n the presence of serum from PC-immunized mice, sug-
esting that the increase of anti-PC antibodies in the serum
f the latter blocked, at least partially, the oxLDL uptake.
his is likely an important mechanism that explains the
theroprotection conferred by PC immunization.
The present findings show that directly targeted immu-
ization to the PC epitope reproduces the beneficial effect
bserved in pneumococcal and oxLDL antiatherosclerotic
accination protocols. Restricting the immune response to
he minimal epitope while achieving equivalent therapeutic
ffect represents a major advance in the search for a
traightforward, safe, and comprehensive vaccination
gainst atherosclerosis.
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